Study: USPSTF Mammogram Recs Based on Inaccurate Information

Article

The number of women who must undergo mammograms to prevent one breast cancer death is lower than stated by the U.S. Preventative Services Task Force, researchers found.

The number of women who must undergo mammograms in order to prevent one breast cancer death is lower than stated by the U.S. Preventative Services Task Force (USPSTF), according to a study published in the March issue of the American Journal of Roentgenology.

The USPSTF used incorrect numbers in their calculations, said researchers, which were then used in 2009 to recommend that women aged 40 to 49 years not receive annual mammograms. It was claimed that the potential harm from the tests outweighed potential benefits. The new recommendation suggested that women consult with their physician regarding when screening should be done.

The erroneous calculation was made on the number of women who were invited to undergo a screening mammography, not the actual number of women who went through with the procedure, according to researchers R. Edward Hendrick and Mark A. Helvie.

The modeling used by the USPSTF showed that 746 women needed to be screened to save one life. When the number of women who underwent the mammogram was used instead of the total number, researchers found that only 84 women needed to be screened annually, between the ages of 40 and 84 years, to save one life.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.